Strategy Inc. (MSTR), a medical device consulting services company, on Thursday announced it has entered into a sales agreement to issue and sell shares of its 10% Series A Perpetual Strife Preferred Stock at $0.001 per value per share with an aggregate offering price of up to $2.1 billion, known as ATM program.
The company intends to use the net proceeds for general corporate purposes, including the acquisition of bitcoin, and for working capital.
The sale of the perpetual strife preferred stock will take place on May 22, under the existing shelf registration statement, effective January 27, 2025.
In the pre-market trading, Strategy is 1.67% higher at $409.41 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.